Vaccitech Prepares For IPO, But AZ COVID-19 Vaccine Safety Fears Cloud Launch
Pipeline Candidates Use Same Platform
The UK biotech aims to raise $100m, but will need to tackle safety concerns to secure a long-term future.

The UK biotech aims to raise $100m, but will need to tackle safety concerns to secure a long-term future.